𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Weight-Based Dosing of Yttrium 90 Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

✍ Scribed by Wiseman, Gregory A.; Conti, Peter S.; Vo, Katie; Schilder, Russell J.; Gordon, Leo I.; Emmanouilides, Christos; Silverman, Dan H.; Witzig, Thomas E.; Darif, Mohamed; Molina, Arturo

Book ID
119935966
Publisher
CIG Media Group, LP.
Year
2007
Tongue
English
Weight
106 KB
Volume
7
Category
Article
ISSN
1557-9190

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Long-term responses in patients with rec
Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan
✍ Thomas E. Witzig; Arturo Molina; Leo I. Gordon; Christos Emmanouilides; Russell πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 205 KB

## Abstract ## BACKGROUND. Radioimmunotherapy with radiolabeled monoclonal antibodies to CD20 produces a high response rate in patients with recurring non‐Hodgkin lymphoma (NHL), but the durability of those remissions is not well defined. ## METHODS. Data on patients with recurring NHL treated w